Antibiotice S.A. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was RON 376.76 million compared to RON 346.78 million a year ago. Net income was RON 29.94 million compared to RON 26.39 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.95 RON | +4.24% |
|
-1.99% | +111.47% |
06-06 | Antibiotice S.A. announced that it expects to receive $108.96 million in funding | CI |
05-15 | Antibiotice S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+111.47% | 426M | |
+55.32% | 815B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |
- Stock Market
- Equities
- ATB Stock
- News Antibiotice S.A.
- Antibiotice S.A. Reports Earnings Results for the Full Year Ended December 31, 2021